cancer Archives - Page 4 of 4 - NFCR


Minor League Baseball and Play4TheCure

For the second year in a row, Play4TheCure and minor league baseball are teaming up this summer to raise money and awareness for cutting-edge cancer research. The program was started by National Foundation for Cancer Research (NFCR) Youth Ambassador Ally Minker.

Inspired by the passing of her grandfather, Ally took it upon herself to motivate others and advance the cause towards a cure for cancer by involving as many baseball teams as possible. Baseball was one of her granfather’s greatest passions and he imparted that to Ally. So naturally, she turned to the community he loved so much to honor his memory.Primary_Logo_Color

This year, teams in the Carolina League as well as the Quad City River Bandits have heeded Ally’s call and committed games to the Play4TheCure mission. The growth of the program within the sport of baseball is a testament to Ally’s dedication to serving others and saving lives through cancer research.

Here’s a list of teams participating this year:

  • Wilmington Blue Rocks – 7/30/16 – 7:05 PM vs. Frederick Keys – BUY TICKETS and be sure to use promo code “PLAY” | $2 for every ticket sold will go to support cancer research
  • Quad Cities River Bandits (Davenport, IA) – 8/7/16 – 1:15 PM vs. Burlington Bees
  • Ft. Myers Miracles – 8/11/16 – 7:05 PM – vs. Charlotte Stone Crabs
  • Frederick Keys – 8/16/16 – 6:00 PM – vs. Lynchburg Hillcats
  • Charlotte (FL) Stone Crabs – 8/20/16 – 6:05 PM – vs. Bradenton Marauders
  • Tampa Yankees – 8/27/16 – 6:35 PM – vs. Brevard County Manatees
Read more

Boston Cannons to Help The National Foundation for Cancer Research

Boston Cannons to Help The National Foundation for Cancer Research with a Special Play4TheCure® Game Night on June 23, 2016help NFCR via Boston Cannons“Cannons Fighting Cancer” will mobilize the lacrosse community to recognize inspirational individuals and raise funds for organizations instrumental in the fight against cancer

 Bethesda, MD –  June 10, 2016 The National Foundation for Cancer Research (NFCR) is proud to welcome The Boston Cannons as the first Major League Lacrosse team to step up and  Play 4 the Cure®.

The Boston Cannons will host their inaugural “Cannons Fighting Cancer” initiative at the team’s home game on June 23 at Harvard Stadium against the Chesapeake Bayhawks. Cannons Fighting Cancer will unite the lacrosse, medical and research communities to raise funds and awareness for philanthropic and research organizations that are focused on finding a cure for cancer and providing services, support and care for individuals and families who are impacted by the disease. The Cannons have partnered with The National Foundation for Cancer Research (NFCR) and its Play4theCure® platform as the primary beneficiary for this special game night.

Cannons Fighting Cancer will bring together and honor members of the Greater Boston medical, science, philanthropic, survivor and lacrosse communities for their continuous efforts in the fight against cancer. Cannons fans can nominate inspirational individuals making an impact against cancer to be recognized at the game by sharing their story on Twitter and Instagram using the hashtag #CannonsFightingCancer. Nominations can also be emailed to

“It brings great pride that our organization is able to gather the lacrosse community together with members of the medical and research communities to support those who are helping to combat this disease,” said President of the Boston Cannons, Ian Frenette. “We want to honor those who are making a difference in the fight cancer and raise funds for organizations that are working diligently to find a cure.”

The Boston Cannons and The National Foundation for Cancer Research (NFCR) are also encouraging the Greater Boston and New England lacrosse community to get involved with Cannons Fighting Cancer through NFCR’s Play4theCure® initiative, which delivers much needed funding toward Cancer Fighting Labs in Boston. Participating teams will have the opportunity to win Cannons prizes for their fundraising efforts. Lacrosse teams can register to Play4theCure® by visiting

Non-lacrosse players can also get involved in Cannons Fighting Cancer by supporting a Play4theCure® team or donating directly to Play4theCure® with the Boston Cannons through the Cannons website and at

“We are so grateful for this opportunity to partner with the Boston Cannons to shine a bright light on the cutting edge cancer research being done in laboratories in greater Boston,” said Dave Bjork, Cancer Research Evangelist for NFCR. “As the first professional sports franchise to #Play4TheCure, the Cannons are taking a leadership position in raising much needed funding and awareness of the Boston medical and research community.”

For more information about Cannons Fighting Cancer and how to get involved, please visit

About the Boston Cannons

The Boston Cannons are one of the founding franchises of Major League Lacrosse, the premier professional outdoor lacrosse league. They began play in June 2001 and won their first MLL Championship on August 28, 2011. For their 16th season, the Cannons will host seven home games back at Harvard Stadium under the leadership of new Head Coach, Sean Quirk. With nine teams competing in 2016, each team will have an additional bye week, and will also play two games over a four-day span once during the season. For more information, call the front office at 617-746-9933 or visit

About NFCR

For more than 43 years, the National Foundation for Cancer Research has focused attention on areas of cancer research that show promise but would otherwise go unfunded. NFCR is dedicated to supporting high risk/high reward cancer research and public education relating to prevention, early diagnosis, better treatments and, ultimately, a cure for all types of cancer.

Contacts:  Rachel Murphy, Boston Cannons: 603-988-2861 or
Kevin Flight, Elevate Communications: 781-439-7140 or
NFCR: 301-654-1250 ask for Play4theCure or
Keith Spiro, KeithSpiroMedia: 617-249-4380 or


Read more

The First Successful Clinical Trial

Clinical Trial and translational medicine. Our CEO and son of the Founder of NFCR likes to talk history. Franklin C. Salisbury, Jr. notes the coincidence, perhaps, that the Salisbury name has long been associated with unheralded basic research that leads to major breakthroughs. Clinical trial and translational medicine –  bring work from lab to patient bedside and is not really a new trend.

HMS Salisbury site of first clinical trialThe HMS Salisbury was a 50 gun British Warship, built at East Cowes, Isle of Wight and launched  on January 29, 1746.  James Lind was the Royal Navy surgeon who studied treatments for scurvy “on board the Salisbury at sea” in 1747.1747 year of the first ever clinical trial

We all remember the story that lemons and oranges cured scurvy and was discovered aboard a navy vessel  but who besides our Franklin would think to connect HMS Salisbury with clinical trials done today. And yet, the comparison is an important one.

The Salisbury  was said to have some 30-40 members of the crew afflicted by scurvy.  “Yet the roll call shows at most one or two as sick during this entire voyage on which six men “departed this life”. This suggests a culture of official denial of sickness at sea, one of many possible reasons, perhaps, why Lind’s work was neglected says Graham Sutton in his essay James Lind aboard Salisbury (Sutton G (2004) James Lind aboard Salisbury)

Official Denial is an interesting phrase. One perhaps that has a place today in our world of blockbuster breakthroughs.There is an interesting bridge between Salisbury, Scurvy, Citrus, Vitamin C and the cancer research supported by NFCR. That connection is Albert Szent-Györgyi.

He was the co-founder of NFCR along with Franklin Salisbury’s dad. Szent-Györgyi was credited with discovering Vitamin C and received the Nobel Prize in 1937. He went on to state his belief that” Cancer is a disease that can be cured,” and the rest is history. For more than 43 years NFCR has been supporting basic lab research into the causes, prevention and treatment of cancer.  The Albert Szent-Györgyi Prize for Progress in Cancer Research is named in honor of Doctor Albert Szent-Györgyi and is a symbol of NFCR’s enduring commitment to uphold Dr. Szent-Györgyi’s vision of curing cancer through innovation and collaboration.

NFCR funded scientists can attest to the need for long term support of basic research. Today’s breakthroughs are often the result of decades of meticulous work built on the work of previous generations. Clinical trial make a difference.   The two men on board the Salisbury that were assigned to the citrus fruit treatment recovered. So too is our hope that those who participate in today’s clinical trials are the lucky ones.


Read more

Green Goddess: Healthy Anti-Cancer Smoothie Recipe



Eating a colorful diet is a good way to make sure you’re getting a variety of vitamins and nutrients that can help prevent cancers. This recipe mixes a few colors from the rainbow and ends up with the “G” in ROY G BIV.

The green goddess smoothie adds a variety of superfoods to your day; you’ll get vitamins, minerals, enzymes, fiber and antioxidants in this delicious drink.

Serves approximately 4 cups

  • 2 cups of purified water
  • 5 cups of spinach leaves
  • ½ lemon squeezed
  • 1 frozen banana
  • 1 granny smith apple
  • 1 ripe pear
  • (Optional) berries and/or a splash of your favorite juice or cider


  1. In a high speed blender, add all ingredients
  2. Pulse for 2-3 minutes or until items are liquefied


Read more